Skip to main content

Table 4 Brain imaging findings

From: Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C

Patient

MRI before miglustat

Follow-up MRI on miglustat

MRS before miglustat

MRS follow-up on miglustat

Early infantile

   

#2

Slight white matter atrophy

M9: stable

ND

M6: normal

#3

Deep WMSA

M12: white matter atrophy affecting the corpus callosum and cortex

Normal

ND

#4

Deep WMSA and cortical atrophy

M24: severe WMSA

Low NAA and high Cho

M12–M24: low NAA, normal Cho, high myo-inositol

#5

ND

ND

ND

 

#6

Deep WMSA and minimal atrophy of the cerebellar vermis

M12: stable

Normal

M12: normal

#7

Periventricular and oval centre WMSA

M12: thinning of the periventricular white matter

Normal

M12: low NAA, high Cho/NAA ratio

#8

Periventricular and subcortical WMSA, and thinning of the corpus callosum and middle cerebellar peduncles

M12: stable

ND

M12: low NAA

#9

Diffuse WMSA

M8: diffuse WMSA and slight atrophy

Low NAA, high Cho, high Cho/NAA

M8: stable

Late infantile

   

#10

Periventricular WMSA

M12–M 48: slowly progressing white matter atrophy

Normal

M12–M48: low NAA, normal Cho

  

M54: stable

  

#11

Normal

ND

ND

ND

#12

Diffuse WMSA

M12: overall atrophy especially in the cerebellar vermis

Normal

ND

#13

Diffuse WMSA

M9: slight cerebellar atrophy

Normal

ND

#14

Normal

M18: signs of cortical-subcortical atrophy in the sub- and sus-tentorial regions

Normal

M18: low NAA, high Cho, M24: normal

#15

WMSA in the left oval centre, and onset of cerebellar atrophy

ND

NAA/Cr ratio reduced

ND

#16

Periventricular WMSA, cortical and cerebellar atrophy

ND

Normal

ND

#17

Normal

ND

ND

ND

Juvenile

   

#18

Periventricular WMSA

M12: stable

ND

M12: normal

#19

Posterior periventricular WMSA and slight cortical atrophy

ND

Normal

ND

#20

Normal

M18 and M30: slight cortical atrophy

M0: high myo-inositol

M18: high myo-inositol, M30: high Cho/NAA ratio

  1. Cho = choline; M = month on miglustat therapy; MRI = magnetic resonance imaging; MRS = magnetic resonance spectroscopy; NAA = N-acetylaspartate; ND = not done; WMSA = white matter signal abnormalities.